Publicaciones en colaboración con investigadores/as de Hospital Clínico San Carlos de Madrid (2)

2019

  1. High prognostic value of measurable residual disease detection by flow cytometry in chronic lymphocytic leukemia patients treated with front-line fludarabine, cyclophosphamide, and rituximab, followed by three years of rituximab maintenance

    Haematologica, Vol. 104, Núm. 11, pp. 2249-2257

2014

  1. Hairy cell leukemia treated initially with purine analogs: A retrospective study of 107 patients from the Spanish Cooperative Group on Chronic Lymphocytic Leukemia (GELLC)

    Leukemia and Lymphoma, Vol. 55, Núm. 5, pp. 1007-1012